Open AccessPatterns of Continuous Glucose Monitor Use in Young Children Throughout the First 18 Months Following Type 1 Diabetes Diagnosis
Author(s) -
Manuela Sinisterra,
Christine H. Wang,
Brynn E. Marks,
John R. Barber,
Carrie Tully,
Maureen Monaghan,
Marisa E. Hilliard,
Randi Streisand
Publication year - 2021
Publication title -
diabetes technology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.142
H-Index - 88
eISSN - 1557-8593
pISSN - 1520-9156
DOI - 10.1089/dia.2021.0183
Subject(s) - medicine , psychosocial , type 1 diabetes , continuous glucose monitoring , pediatrics , intervention (counseling) , diabetes mellitus , young adult , public health , gerontology , psychiatry , endocrinology , nursing
Objective: To describe sociodemographic and parent psychosocial characteristics associated with patterns of continuous glucose monitor (CGM) use across the first 18 months post-type 1 diabetes (T1D) diagnosis among young children. Methods: One hundred fifty-seven parent-child dyads enrolled in a behavioral intervention for parents of young children (1-6 years) newly diagnosed with T1D. Parents reported on baseline sociodemographic characteristics and psychosocial functioning; child CGM use was assessed at five time points during the first 18 months post-diagnosis. Results: Most participants (81.8%) used CGM at least once. Four CGM trajectories emerged ( always, later/stable, inconsistent, and never) . Participants with private insurance were more likely to be in the always , later/stable , or inconsistent groups versus the never group. Youth in the always and later/stable groups had lower mean HbA1c at 18 months than those in the never group. Conclusions: Given the health benefits of CGM, further exploration of barriers to CGM use in families with public health insurance is needed. ClinicalTrials.gov identifier: NCT02527525.